Q4 2025 Earnings Presentation February 18, 2026 Xandra Velzeboer Netherlands Short Track Speed Skating Forward-Looking Statements This presentation contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are "forward-looking statements" for purposes of federal and state securities laws, including any projections of earnings, re ...

Exhibit 99.1 Herbalife Delivers Fourth Quarter and Full-Year Net Sales Growth, Net Sales and Adjusted EBITDA Exceed Guidance Cristiano Ronaldo Invests $7.5 Million in Herbalife's Pro2col™ Technology LOS ANGELES, February 18, 2026 – Herbalife Ltd. (NYSE: HLF) today reported financial results for the fourth quarter and year ended December 31, 2025: Highlights Fourth Quarter 2025 Full-Year 2025 Recent Developments ● In February, global sports icon Cristiano Ronaldo, invested $7.5 million and provided sponsorsh ...

Financial Performance - Net sales for the year ended December 31, 2025, were $5,037.5 million, an increase of $44.4 million, or 0.9%, compared to 2024[285]. - Net income attributable to Herbalife for 2025 was $228.3 million, or $2.20 per diluted share, a decrease of $26.0 million, or 10.2%, from 2024[286]. - The Primary Reporting Segment reported net sales of $4,758.4 million for 2025, an increase of $62.9 million, or 1.3%, compared to 2024[290]. - Contribution margin for the Primary Reporting Segment was $2,037.2 million, or 42.8% of net sales, an increase of $32.9 million, or 1.6%, from 2024[293]. - The 0.9% increase in net sales for 2025 was primarily driven by a 3.2% favorable impact of price increases, offset by a 1.6% unfavorable impact from foreign currency fluctuations and a 0.5% decrease in sales volume[285]. - Gross profit was $3,922.9 million for the year ended December 31, 2025, maintaining a gross profit margin of 77.9%[314]. - Gross profit as a percentage of net sales was flat for the year ended December 31, 2025, compared to 2024, with a favorable impact of price increases of 78 basis points and other cost changes of 9 basis points, offset by unfavorable impacts from foreign currency fluctuations of 65 basis points and higher inventory write-downs of 10 basis points[315]. Regional Sales Performance - North America reported net sales of $1,033.0 million for the year ended December 31, 2025, a decrease of $21.4 million, or 2.0%, compared to 2024[296]. - Latin America achieved net sales of $881.2 million for the year ended December 31, 2025, an increase of $48.7 million, or 5.8%, compared to 2024[300]. - EMEA region net sales were $1,114.4 million for the year ended December 31, 2025, reflecting an increase of $29.6 million, or 2.7%, compared to 2024[304]. - Asia Pacific region, excluding China, reported net sales of $1,729.8 million for the year ended December 31, 2025, an increase of $6.0 million, or 0.3%, compared to 2024[307]. - China region net sales were $279.1 million for the year ended December 31, 2025, a decrease of $18.5 million, or 6.2%, compared to 2024[311]. - In India, net sales increased by $44.8 million, or 5.3%, for the year ended December 31, 2025, supported by a reduction in GST rates[308]. Cost Management and Expenses - Selling expenses were $1,782.4 million for the year ended December 31, 2025, representing 35.4% of net sales, a decrease from 35.7% in 2024, primarily due to favorable changes in the mix of products and countries[317][318]. - General and administrative expenses decreased to $1,664.3 million for the year ended December 31, 2025, or 33.0% of net sales, down from 34.6% in 2024, driven by lower labor and benefits costs of $78.3 million[319][320]. - The company continues to assess its cost structure and potential pricing actions in response to ongoing inflationary pressures[284]. Strategic Initiatives - The company’s strategies focus on improving daily consumption approaches and leveraging technology to enhance Member experiences and drive sales[280]. - The company launched new products including a healthy lifespan supplement and MultiBurn, aimed at enhancing member sales capabilities[298]. - The beta version of the Pro2col health and wellness digital platform was unveiled in July 2025, with a successful release in December 2025[299]. Cash Flow and Capital Expenditures - Operating cash flow increased to $333.3 million for the year ended December 31, 2025, compared to $285.4 million in 2024, attributed to higher net income and lower income taxes[328]. - Capital expenditures were $80.5 million for the year ended December 31, 2025, down from $112.2 million in 2024, with significant investments in digital technology initiatives[329]. Debt and Financing - The company issued $800.0 million aggregate principal amount of senior secured notes due 2029, with an interest rate of 12.250% per annum payable semiannually[348]. - The 2024 Term Loan B Facility has an aggregate principal amount of $400.0 million and requires quarterly payments equal to 5.0% of the principal amount per annum, starting September 2024[339]. - The company repaid $981.0 million of long-term debt by extinguishing the 2018 Credit Facility, resulting in a loss on extinguishment of approximately $2.5 million[340]. - As of December 31, 2025, the outstanding principal on the 2029 Secured Notes was $800.0 million, and the company had no borrowings outstanding under the 2024 Revolving Credit Facility[348][346]. - The weighted-average interest rate for borrowings under the 2024 Credit Facility was 11.64% as of December 31, 2025, compared to 10.35% as of December 31, 2024[346]. Working Capital and Assets - The company had positive working capital of $131.8 million as of December 31, 2025, an increase of $218.5 million from negative working capital of $86.7 million in 2024[363]. - Cash and cash equivalents held by Herbalife Ltd. and its U.S. entities totaled $47.8 million as of December 31, 2025[357]. - The company had goodwill of approximately $100.5 million, an increase of $12.8 million from $87.7 million in 2024, primarily due to the acquisition of Link BioSciences Inc.[377]. - The company had marketing-related intangible assets of approximately $310.0 million as of December 31, 2025, with no impairment recorded during the years ended December 31, 2025, and 2024[377]. Tax and Accounting - The company believes it is more likely than not that the net carrying value of deferred income tax assets will be realized, although realization is not assured[380]. - The company initiated changes to its corporate entity structure, including intra-entity transfers of intellectual property to a European subsidiary, resulting in a step-up in tax basis on the fair value of the intellectual property[380]. - Tax benefits from uncertain tax positions are recognized only if it is more likely than not that the position will be sustained upon examination by taxing authorities[381]. - The company accounts for foreign currency transactions in accordance with FASB ASC Topic 830, with foreign subsidiaries' asset and liability accounts translated into U.S. dollars at period-end exchange rates[383].

Core Viewpoint - Herbalife Ltd. reported strong financial results for Q4 and the full year of 2025, indicating solid momentum with net sales growth and adjusted EBITDA exceeding guidance [1] Financial Performance - The company achieved net sales growth in both Q4 and the entire year of 2025 [1] - Adjusted EBITDA for the year was above the company's guidance, showcasing operational efficiency and profitability [1] Strategic Initiatives - Cristiano Ronaldo's investment in Pro2col is highlighted as a strategic move to enhance personalized nutrition and wellness on a global scale [1] - The collaboration aims to integrate science, data, AI, innovation, and community to improve health and performance for millions [1]

LOS ANGELES--(BUSINESS WIRE)--Herbalife Ltd. (NYSE: HLF), a premier health and wellness company, community and platform, today announced global sports icon Cristiano Ronaldo acquired a 10% equity interest in HBL Pro2col Software, LLC, an indirect wholly-owned subsidiary of Herbalife that holds the Pro2col technology. Pro2col is Herbalife's next-generation, digital, personalized health and wellness operating system, designed to drive daily engagement, sustainable behavior change, and measurable. ...

Core Viewpoint - High Liner Foods has launched new Sea Cuisine® Guinness™ Battered Fish Strips and Shrimp, combining the flavors of Guinness with premium seafood to enhance at-home dining experiences [1] Product Overview - The new products include Sea Cuisine Guinness Battered Fish Strips and Shrimp, crafted with responsibly sourced wild-caught Alaska Pollock and shrimp, coated in a batter infused with Guinness flavor [1] - The fish strips contain 12g of protein and the shrimp contains 10g of protein, both are non-alcoholic and designed to deliver restaurant-quality meals at home [1] Market Availability - The products are available in 1,500 Kroger Family of Companies stores and in a 2lb Club Size at Costco across the United States, with plans for further North American expansion [1] Company Background - High Liner Foods is a leading North American processor and marketer of value-added frozen seafood, with a diverse portfolio of brands sold in grocery and club stores [1] - The company is publicly traded on the Toronto Stock Exchange under the symbol HLF [1] Partnership Insights - The collaboration with Guinness aims to showcase how the stout can enhance the flavor of seafood dishes, providing an authentic pub-style experience at home [1]

Core Insights - Herbalife (HLF.US) is focusing on product innovation, particularly the launch of personalized supplements in 2026 as part of its strategy to emphasize technology and personalized services [1] Group 1: Product Innovation - The company plans to introduce personalized supplements in 2026, aligning with its strategic focus on technology and personalized services [1] - No recent specific events, such as earnings releases or policy changes, have been disclosed as of February 12, 2026 [1] Group 2: Financial Guidance - Herbalife mentioned its full-year performance guidance in the Q3 2025 earnings report, indicating a forward-looking approach to its financial outlook [1]

Core Insights - Herbalife Ltd (HLF) is positioned to potentially continue its earnings-beat streak in upcoming reports, having surpassed earnings estimates by an average of 8.85% in the last two quarters [1] Earnings Performance - In the last reported quarter, Herbalife Ltd achieved earnings of $0.5 per share, exceeding the Zacks Consensus Estimate of $0.47 per share, resulting in a surprise of 6.38% [2] - In the previous quarter, the company was expected to report earnings of $0.53 per share but delivered $0.59 per share, leading to a surprise of 11.32% [2] Earnings Estimates and Predictions - Estimates for Herbalife Ltd have been trending higher, influenced by its history of earnings surprises [4] - The company currently has a positive Earnings ESP of +9.47%, indicating that analysts have recently become more optimistic about its earnings prospects [7] - The combination of a positive Earnings ESP and a Zacks Rank of 3 (Hold) suggests a strong possibility of another earnings beat in the upcoming report scheduled for February 18, 2026 [7] Earnings ESP Insights - The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate, with the Most Accurate Estimate reflecting the latest analyst revisions [6] - Stocks with a positive Earnings ESP and a Zacks Rank of 3 or better have historically produced a positive surprise nearly 70% of the time [5]

Core Viewpoint - Herbalife Ltd. (NYSE:HLF) is recognized as one of the best-performing affordable stocks under $40, with analysts providing mixed ratings and price targets reflecting differing outlooks on the company's future performance [1][2]. Group 1: Analyst Ratings and Price Targets - Mizuho Securities reiterated a Hold rating on Herbalife, raising the price target from $11 to $13, indicating cautious optimism about the stock's performance [1]. - Maxim Group initiated a Buy rating on Herbalife with a price target of $20, suggesting a more bullish outlook on the company's potential [1]. Group 2: Growth Expectations and Valuation Concerns - Mizuho analysts expect Herbalife to grow and outperform by 2026, but they caution that weak fundamentals and macroeconomic uncertainties are contributing to compressed valuations [2]. - Maxim Group believes a turnaround is underway for Herbalife, which will strengthen its position in the health and wellness sector, citing resolved regulatory concerns and improved distributor relationships [3]. Group 3: Company Overview - Herbalife Ltd. is a leading nutrition company offering health and wellness products across approximately 95 markets globally, including categories such as weight management, targeted nutrition, energy, sports, and fitness products [4].

Group 1 - Maxim analyst Anthony Vendetti initiated coverage of Herbalife (HLF) with a Buy rating and a price target of $20 [1] - A turnaround is underway for Herbalife, enabling the company to solidify its status as a leading provider of health and wellness products [1] - Maxim believes that U.S. regulatory concerns have been resolved, leading to a more sustainable business model through changes in distributor compensation alignment with sales to end users [1]